When Direct Oral Anticoagulants Should Not Be Standard Treatment

Antoine Bejjani; Candrika D. Khairani; Ali Assi; Gregory Piazza; Parham Sadeghipour; Azita H. Talasaz; John Fanikos; Jean M. Connors; Deborah Siegal; Geoffrey D. Barnes; Karlyn A. Martin; Dominick J. Angiolillo; Dawn Kleindorfer; Manuel Monréal; David Jiménez; Saskia Middeldorp; Mitchell S.V. Elkind; Christian T. Ruff; Samuel Z. Goldhaber; Harlan M. Krumholz; Roxana Mehran; Mary Cushman; John W. Eikelboom; Professor Gregory Lip; Jeffrey I. Weitz; Renato D. Lópes; Behnood Bikdeli

doi:10.1016/j.jacc.2023.10.038

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2013

Should oral anticoagulants be restarted after warfarin-associated cerebral haemorrhage in patients with atrial fibrillation?

Maurizio Paciaroni, Giancarlo Agnelli

Article2018

Clinically relevant non-major bleeding with oral anticoagulants: non-major may not be trivial.

Laura Franco, Cecilia Becattini, Simone Vanni, Rodolfo Sbrojavacca, Cinzia Nitti, Giorgia Manina, Luca Masotti, Fulvio Pomero, Sergio Cattinelli, Roberto Cappelli, Roberta Re, Giancarlo Agnelli

Article2023

Pharmacokinetics and pharmacodynamics of direct oral anticoagulants

Ben Hindley, Professor Gregory Lip, Asako McCloskey, Peter E. Penson

Article2019

Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism

Michela Giustozzi, Laura Franco, Maria Cristina Vedovati, Cecilia Becattini, Giancarlo Agnelli

Letter2022

Women self-reporting PCOS symptoms should not be overlooked

Terhi Piltonen, Laure Morin‐Papunen, Meri‐Maija Ollila, Juha S. Tapanainen, Riikka K. Arffman, Paul M Ridker, Stephen Franks